DNTH vs NOK · rev $6.2M vs P/E 87, $78.04B cap
Dianthus Therapeutics Inc. (DNTH) versus Nokia Corp ADR (NOK) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Nokia Corp ADR (NOK) is a communication equipment company listed on NYSE.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
NOK does not have a complete income-statement cache yet.
DNTH currently screens at market cap $4.40B. NOK currently screens at market cap $78.04B and trailing P/E 87.4.
Not investment advice. Open the DNTH and NOK stock pages for the full models.
Not investment advice.